Cystic Fibrosis (CF) is a disease that affects salt and water transport in multiple organs. Many CF patients suffer from abdominal pain and this could be due to intestinal inflammation. However, so far we do not know how many of the CF patients actually do have intestinal inflammation when looking at intestinal specimens. There is a proven connection between chronic inflammation and developing colorectal cancer and over the years more CF patients are developing colorectal cancer. Thus, it becomes increasingly important to look for the presence of intestinal inflammation in CF patients since early treatment may improve their symptoms and reduce the risk for colorectal cancer.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Measure fecal calprotectin levels in stool samples of CF pediatric population to determine prevalence of intestinal inflammation.
Timeframe: Day 1
Assess the correlation between fecal calprotectin levels and abdominal symptoms.
Timeframe: Day 1
Determine the prevalence of intestinal inflammation in adult CF patients based on histological evaluation of intestinal tissues biopsies and fecal calprotectin levels in stool samples.
Timeframe: Day 1
Determine the correlation between fecal calprotectin and histological-proven intestinal inflammation in adult CF patients.
Timeframe: Day 1
Assess the correlation between histological-proven intestinal inflammation and abdominal symptoms in adult CF patients.
Timeframe: Day 1